Literature DB >> 29921406

Diagnosis with spiral CT imaging before gastric carcinoma surgery.

J W Zhou1, Y Y Yan1, W Y Zhang1, L S Wang2, B Z Gao3, X Z Shi1, X D Geng1, Y Huang1.   

Abstract

This study was carried out to study multi-slice spiral CT imaging for patients with gastric carcinoma and explore the values of multi-slice spiral CT imaging in staging prior to gastric carcinoma (GC) surgery. Forty-eight patients with GC underwent multi-slice spiral CT, and the scanning results were compared with the pathological results. The similarity of the results was observed, and the accuracy was calculated. Of 48 patients, 8 did not undergo surgery because of metastasis. In the diagnosis of the remaining 40 patients, the sensitivity of multi-slice spiral CT in the diagnosis of staging of invasive depth of GC was 77.5%; κ = 0.642 in the analysis of consistency; there was no significant difference with the pathological results (p >0.05). The overall accuracy of diagnosis for stage N was 80%. The accuracy of multi-slice CT in detecting distant metastasis of GC was 87.5%. Multi-slice spiral CT can determine and evaluate various metastases of GC. The diagnostic results obtained using multi-slice spiral CT was probably consistent with the pathological results.

Entities:  

Mesh:

Year:  2018        PMID: 29921406

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  2 in total

1.  Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.

Authors:  Wenwen Han; Xiangzhen Bu; Yanli Liu; Fang Liu; Yujie Ren; Yongsheng Cui; Shuhong Kong
Journal:  World J Surg Oncol       Date:  2021-09-18       Impact factor: 2.754

2.  Accuracy evaluation of combining gastroscopy, multi-slice spiral CT, Her-2, and tumor markers in gastric cancer staging diagnosis.

Authors:  Songbo Zhao; Yangang Bi; Zhenfang Wang; Fantao Zhang; Yang Zhang; Yongyun Xu
Journal:  World J Surg Oncol       Date:  2022-05-11       Impact factor: 3.253

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.